The Rise of the Digital Couch: Will Patients Trust AI With Their Mental Health?

By Francesca Bordas

Editor’s Note

Artificial intelligence is entering mental healthcare. Conversational systems can respond to emotional concerns, recognise patterns in information users provide, and offer support outside conventional consultation hours. Their growing capabilities raise questions about patient safety, privacy and the role of healthcare professionals.

At Hezron Insights, we examine how emerging technologies influence communication and public trust. In this guest article, Francesca Bordas explores what AI-supported mental healthcare could look like by 2031 and the decisions healthcare institutions may face along the way.

The future scenarios are illustrative and should not be mistaken for established medical capabilities.

Imagine waking up in 2031 to a notification from your smartwatch.

Your sleep has deteriorated over several nights. Your heart rate has changed, and the device recommends a conversation with a digital mental health assistant.

You explain how you feel. The system remembers earlier conversations, notices changes in your language and recalls that you recently experienced difficulties at work.

Its responses are reassuring. You feel understood.

Yet the system has no emotional experience of its own. It processes information and generates responses based on patterns.

Would you trust it with your mental health?

This possibility is attracting attention as artificial intelligence moves into services that interact directly with patients.

On 30 June 2026, Anthropic announced Claude Science, an AI workbench for scientists, reflecting growing interest in using AI to support scientific discovery.

Such developments may eventually contribute to medical advances, although considerable research and regulatory work separates scientific tools from approved treatments.

In mental healthcare, conversational AI presents a more immediate concern. These systems can communicate with remarkable fluency, even when their capacity to provide clinically reliable support remains uncertain.

The digital couch is already taking shape

People already use conversational AI tools to seek information, reflect on personal difficulties and discuss emotional concerns.

Unlike conventional health websites, these systems allow users to explain their circumstances in ordinary language and receive responses informed by earlier exchanges.

Future mental health platforms may incorporate information from wearable devices, sleep trackers and mood-monitoring applications. Patients could use these tools to document changes in their wellbeing and share relevant information with clinicians between appointments.

The appeal is understandable, particularly where professional mental health services are difficult to access.

According to the World Health Organization’s 2025 report, World Mental Health Today, more than one billion people live with a mental health condition, yet most do not receive adequate care.

Shortages of qualified professionals, inadequate financing and unequal access to treatment contribute to this gap.

Digital mental health services could make certain forms of support more accessible. Patients might obtain basic information, practise exercises recommended by clinicians or monitor their progress between consultations.

Someone uncomfortable discussing personal difficulties face to face may also find it easier to begin with a digital conversation.

Access, however, tells us little about the quality of care.

A chatbot may be available throughout the night without being capable of recognising a psychiatric emergency or responding appropriately to complex symptoms.

Healthcare providers need evidence that these systems can perform their intended functions safely, together with clear arrangements for professional assessment when required.

When therapy meets drug discovery

Artificial intelligence is also influencing pharmaceutical research.

Computational tools allow scientists to examine biological datasets, investigate chemical structures and identify potential compounds for further study.

These developments suggest possible connections between AI-supported mental health services, clinical assessment and future treatments.

Consider a patient whose sleep patterns, mood and daily functioning have changed over several weeks.

A digital platform might organise this information and encourage the patient to seek professional assessment. A psychiatrist could then review the findings alongside the patient’s medical history before deciding whether treatment is appropriate.

AI-assisted research may contribute to developing new medicines for mental health conditions, including those for which existing treatments remain inadequate.

But identifying a promising compound is only an early stage of drug development. Researchers must establish its safety and effectiveness through appropriate investigations, clinical trials and regulatory approval.

Claims that AI-designed antidepressants will automatically work faster or produce fewer side effects than existing medicines remain unsupported.

The potential benefit lies in improving the information available to clinicians and supporting research into treatments that can be properly evaluated.

Better access brings new risks

For people who cannot afford regular counselling, live far from qualified professionals or fear the stigma associated with seeking help, digital mental health services may offer useful assistance.

Patients already receiving treatment could also benefit from tools that support continuity of care.

However, concerns about the safety of AI mental health chatbots are supported by emerging research.

A systematic scoping review published in Healthcare in May 2026 examined 21 studies of generative AI mental health chatbot interventions across 11 countries.

The researchers identified weaknesses in human oversight, crisis referral arrangements and monitoring of adverse events. Documented safety failures included missed indications of suicidal ideation and inaccurate clinical information.

These findings warrant attention because conversational AI can produce reassuring responses despite misunderstanding the seriousness of someone’s circumstances.

For a patient experiencing distress, inappropriate reassurance may delay professional assessment or encourage reliance on unsuitable advice.

Healthcare institutions evaluating these tools should therefore examine how they perform when users describe symptoms indirectly, provide incomplete information or require urgent assistance.

The way people communicate during emotional distress may differ considerably from the carefully structured questions used during routine system testing.

The trust gap: When AI sounds more reliable than it is

People often judge credibility through communication.

We notice when someone remembers what we have said, asks thoughtful questions or responds sensitively to a difficult experience.

Conversational AI can reproduce many of these behaviours.

For someone experiencing anxiety or loneliness, an assistant that recalls previous discussions and responds sympathetically may appear unusually attentive.

That impression can become problematic when users assume the system’s apparent understanding reflects clinical competence.

An AI platform might respond compassionately to someone describing depression while overlooking information that a trained professional would consider significant.

The World Health Organization’s 2024 guidance on large multimodal AI models identifies risks including inaccurate information, bias and excessive reliance on automated recommendations.

Mental healthcare makes these concerns particularly sensitive because patients may disclose intimate information or act on suggestions affecting their wellbeing.

Privacy introduces further complications.

Conversations about mental health may reveal personal experiences, family relationships and medical conditions that individuals would hesitate to share elsewhere.

Patients need to understand where this information is stored, who can access it and whether it may be used for purposes beyond providing support. They should also know how long their records will be retained and what happens when they withdraw consent.

Healthcare institutions have a responsibility to explain these arrangements clearly and establish appropriate safeguards.

A convincing conversation may encourage someone to trust a platform. That trust needs to be supported by evidence of reliability and responsible handling of personal information.

Why human connection still matters

If an AI assistant can remember someone’s experiences, offer encouragement and recommend useful exercises, how much of the therapeutic relationship could technology reproduce?

Some patients may appreciate digital support, particularly when seeking information or practising techniques recommended by a professional.

Others require sustained interaction with a qualified therapist, especially when dealing with trauma, complex psychiatric conditions or difficulties affecting personal relationships.

Therapists bring clinical knowledge, experience and professional responsibility. Their judgement also draws on aspects of a patient’s circumstances that may not emerge during a digital exchange.

The interpersonal relationship can itself contribute to treatment.

Another concern involves emotional dependence on AI companions.

Someone who repeatedly seeks reassurance from a digital system may begin relying on it in ways that affect relationships outside the platform.

The long-term consequences require further research. It would be premature to assume that such interactions are necessarily harmful or beneficial.

Understanding how people use these systems over time will help establish where they can contribute meaningfully to mental healthcare.

Five questions healthcare institutions should answer before introducing AI mental health support

Healthcare institutions considering AI mental health chatbots or digital therapy platforms should examine five issues before deployment.

1. Has the technology been clinically evaluated?

Is there independent evidence supporting its safety and effectiveness for the intended patients and purpose?

A system’s ability to hold convincing conversations provides insufficient evidence of clinical reliability.

2. What happens when a patient needs urgent assistance?

Can the platform recognise situations requiring professional attention, and are reliable arrangements in place to direct patients to appropriate services?

These procedures need to be tested under realistic conditions.

3. How is sensitive information protected?

Who controls patient data, where is it stored, who can access it and how are consent and confidentiality managed?

Patients should receive understandable explanations of these arrangements before sharing personal information.

4. Does the system understand the local context?

Can it interpret relevant languages and cultural expressions of distress while recommending services that patients can realistically access?

For African healthcare institutions, this deserves particular attention. A platform developed and tested elsewhere may perform differently when used in communities with other languages, cultural expectations and healthcare arrangements.

5. Who is accountable when something goes wrong?

Who supervises the platform, investigates incidents and takes responsibility for correcting problems?

Clear institutional responsibility should be established before the technology becomes part of patient care.

These questions provide a practical governance checklist. They do not replace formal clinical, legal, regulatory or data-protection assessments.

Looking ahead

By 2031, mental healthcare may involve closer connections between wearable devices, digital support platforms and conventional clinical services.

Patients could monitor symptoms, share selected information with clinicians and receive assistance between appointments.

AI-assisted drug discovery may also contribute to future treatments, provided promising compounds undergo rigorous scientific and regulatory evaluation.

For communities where mental healthcare remains difficult to access, these developments are worth exploring.

But decisions about adopting them should reflect the evidence available for specific applications and the circumstances of the people expected to use them.

Patients will still need reliable information, confidential services and qualified professionals responsible for their care.

The digital couch may become a familiar part of mental healthcare. Its value will depend on the quality of support patients receive and the safeguards available when technology fails to meet their needs.

About the Author

Francesca Bordas is a writer interested in artificial intelligence, psychology, digital innovation and the implications of emerging technologies for society.

Her commentary explores how technological developments may influence healthcare, human behaviour and decision-making, including the ethical questions associated with increasingly sophisticated AI systems.

Editor’s Reflection

By Hezron Ochiel, Founder, Hezron Insights

Francesca Bordas raises an important concern for healthcare institutions. AI can communicate convincingly even when evidence supporting its clinical use remains limited.

This has implications for how organisations introduce emerging healthcare technologies to patients.

A reassuring conversation may create an impression of professional competence. Patients who misunderstand the limitations of a digital platform could delay seeking appropriate medical assistance.

For African healthcare systems, local relevance deserves particular attention.

An application developed and tested elsewhere may struggle to interpret how patients describe emotional distress in local languages. Its recommendations may also refer people to services that are unavailable or unaffordable.

My research into AI-generated information across African contexts has examined the representation of locally produced sources. Although it did not evaluate mental health applications, the findings highlight the importance of investigating whose knowledge informs AI responses and whether that information is relevant to local audiences.

Healthcare institutions should involve clinicians, patients and local communities when evaluating AI-supported mental health services. Communication professionals can help ensure that public explanations accurately reflect the available evidence and make the technology’s limitations understandable.

These discussions deserve attention before implementation, when institutions still have opportunities to influence the design of services and the safeguards governing their use.

References

  1. World Health Organization. (2025). World Mental Health Today: Latest Data.
  2. Olisaeloka, L., Richardson, C. G., Wang, A. Y., Munthali, R. J., & Vigo, D. V. (2026). Safety Mechanisms and Risk Mitigation in Generative AI Mental Health Chatbots: A Systematic Scoping Review. Healthcare, 14(10), 1395.
  3. World Health Organization. (2024). Ethics and Governance of Artificial Intelligence for Health: Guidance on Large Multi-Modal Models.
  4. Anthropic. (2026, 30 June). Claude Science, an AI Workbench for Scientists, Is Now Available.